ArticleCureus2026
A Rare Case of Large Cell Neuroendocrine Carcinoma of the Thymus Presenting as a Lower Neck Mass in a Young Male Patient.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large cell neuroendocrine carcinoma (LCNEC) of the thymus is a strikingly unusual and high-grade thymic tumor with a poor prognosis. Studies with large series of patients on the clinical, epidemiological, and biological behavior of the disease are not available due to its low prevalence and short survival. We report here such a rare case of LCNEC in a 33-year-old male patient who primarily presented with a mass in the suprasternal and left supraclavicular regions with multiple bilateral cervical lymph nodes. Fine needle aspiration cytology from the neck mass demonstrated hypercellular smears with numerous variably sized, loosely cohesive clusters, including large hypercellular ones, of medium-sized atypical cells with scant cytoplasm, hyperchromatic nuclei, and granular chromatin, with a few having small, inconspicuous nucleoli. Peripheral nuclear palisading or rosette-like structures were noted in many places. An anterior mediastinal invasive mass lesion, possibly of thymic origin, extending to the neck and encasing the major vessels, including branches of the aortic arch, without any evidence of lung parenchymal extension, with multiple bilateral cervical lymph nodes was identified on contrast-enhanced computed tomography. Incisional biopsy revealed large atypical cells mostly arranged in nests, solid sheets, and trabeculae, with hyperchromatic nuclei, coarse chromatin, a moderate amount of eosinophilic cytoplasm, frequent mitoses, and apoptotic bodies. The cells were immunopositive for pancytokeratin, EMA, synaptophysin, chromogranin A, CD56, and TTF-1, with a high Ki-67 labeling index, while negative for all other relevant markers. Misdiagnosis or delay in the correct diagnosis of this rare but aggressive thymic tumor may lead to disease spread and progression to systemic involvement. Many such cases of thymic LCNEC need to be studied to design and optimize standard management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.